Immunic Inc - ESG Rating & Company Profile powered by AI
This page includes a questions and answers section about Immunic Inc. The page displays a zero-cost E,S&G assessment for Immunic Inc. Full ESG assessment of Immunic Inc can be accessed by signing up for free.
Immunic Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1967 | Hospira Inc | 0.3 | Low |
1967 | PRA Health Sciences Inc | 0.3 | Low |
1970 | Immunic Inc | 0.0 | Low |
1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
1970 | CTC Bio Inc | 0.0 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Immunic Inc have an accelerator or VC vehicle to help deliver innovation?
Does Immunic Inc disclose current and historical energy intensity?
Does Immunic Inc report the average age of the workforce?
Does Immunic Inc reference operational or capital allocation in relation to climate change?
Does Immunic Inc disclose its ethnicity pay gap?
Does Immunic Inc disclose cybersecurity risks?
Does Immunic Inc offer flexible work?
Does Immunic Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Immunic Inc disclose the number of employees in R&D functions?
Does Immunic Inc conduct supply chain audits?
Does Immunic Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Immunic Inc conduct 360 degree staff reviews?
Does Immunic Inc disclose the individual responsible for D&I?
Does Immunic Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Immunic Inc disclose current and / or historical scope 2 emissions?
Does Immunic Inc disclose water use targets?
Does Immunic Inc have careers partnerships with academic institutions?
Did Immunic Inc have a product recall in the last two years?
Does Immunic Inc disclose incidents of discrimination?
Does Immunic Inc allow for Work Councils/Collective Agreements to be formed?
Has Immunic Inc issued a profit warning in the past 24 months?
Does Immunic Inc disclose parental leave metrics?
Does Immunic Inc disclose climate scenario or pathway analysis?
Does Immunic Inc disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Immunic Inc disclose the pay ratio of women to men?
Does Immunic Inc support suppliers with sustainability related research and development?
Does Immunic Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Immunic Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Immunic Inc involved in embryonic stem cell research?
Does Immunic Inc disclose GHG and Air Emissions intensity?
Does Immunic Inc disclose its waste policy?
Does Immunic Inc report according to TCFD requirements?
Does Immunic Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Immunic Inc disclose energy use targets?
Does Immunic Inc disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Immunic Inc have a policy relating to cyber security?
Have a different question?
Potential Risks for Immunic Inc
These potential risks are based on the size, segment and geographies of the company.
Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and other chronic inflammatory and autoimmune diseases, as well as to treat coronavirus disease. The company is also developing IMU-935, an inverse agonist of ROR"t; and IMU-856 for the restoration of the intestinal barrier function in patients suffering from diseases, such as inflammatory bowel disease, irritable bowel syndrome with diarrhea, immune checkpoint inhibitor induced colitis, and other intestinal barrier function diseases. Immunic, Inc. is headquartered in New York, New York.